This page links to some files in Portable Document Format (PDF).


Louise Wideroff

Louise Wideroff, PhD, is a Program Director in the Risk Factor Monitoring and Methods Branch of the Applied Research Program. Her areas of expertise include assessment and use of family history of cancer information, and clinical utility of emerging cellular, molecular, and genomic technologies for cancer prevention, early detection, diagnosis, and treatment. She currently serves as program director for the R01 and R21 Program Announcements entitled "Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies in Cancer Care". She has also served as NCI Project Officer on research contracts addressing family history of cancer accuracy and interpretability, physician use of genetic tests for inherited breast/ovarian and colorectal cancer susceptibility, and cancer risk associated with blood transfusions from cancer survivors.

Dr. Wideroff received her PhD in Epidemiology from the University of Michigan, and her MSPH in Epidemiology from the University of Illinois. Prior to joining the Applied Research Program in 1997, she completed a post-doctoral fellowship in cancer epidemiology in the Division of Cancer Epidemiology and Genetics at NCI. Her doctoral and post-doctoral research focused on human papillomavirus infection and humoral immune response in urogential cancers. During this time, she received laboratory training in nucleic acid and antibody detection methods. Her interests include molecular and modifiable risk factors for cancer progression, and effectiveness of and access to molecular diagnostic tools and targeted therapies in routine clinical care.

Last modified:
29 Jan 2008
Search | Contact Us | Accessibility | Privacy Policy  
Division of Cancer Control and Population Sciences National Cancer Institute Department of Health and Human Services National Institutes of Health The US government's official web portal